Literature DB >> 3780474

Cardiogenic shock. Current concepts in management.

K Balakumaran, P G Hugenholtz.   

Abstract

This article presents a categorisation of circulatory shock and discusses the causes, haemodynamics, and clinical recognition of cardiogenic shock. The first step in the management strategy in cardiogenic shock is to guide the patient from the state of shock to one of managed haemodynamic stability. The therapeutic manoeuvres of this first step constitute the management tactics, which can be grouped under 3 general headings: (a) making the most of a malfunctioning heart; (b) improving the state of the heart; and (c) reducing the demands on the heart. In order to make the most of the heart, i.e. to get the highest possible output at the lowest possible cost, clinicians need to use their judgement in stimulating an overtaxed heart on the one hand, and in manipulating the loads on it (the preload and afterload) on the other, for although these methods may be advantageous, they are not without their pitfalls. Efforts to improve the state of the heart often necessitate surgical (e.g. mitral valve replacement) or semisurgical (e.g. coronary angiography and recanalisation) techniques, although intravenous antithrombotic agents may achieve comparable results in a few cases at the bedside. Reducing the demands on the heart is an active process involving the takeover of at least a part of the work of the heart by ancillary devices such as the intra-aortic balloon pump, and of the work of breathing by intubation and artificial ventilation. The individuality of each case of cardiogenic shock emphasises the need for empirical modulation of therapy based on feedback information obtained by haemodynamic monitoring.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780474     DOI: 10.2165/00003495-198632040-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

Review 1.  Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.

Authors:  L I Goldberg; Y Y Hsieh; L Resnekov
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

2.  Phentolamine for vasodilator treatment of severe heart-failure.

Authors:  P A Majid; B Sharma; S H Taylor
Journal:  Lancet       Date:  1971-10-02       Impact factor: 79.321

3.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

4.  Myocardial changes associated with cardiogenic shock.

Authors:  D L Page; J B Caulfield; J A Kastor; R W DeSanctis; C A Sanders
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

5.  The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm.

Authors:  D T Mason; E Braunwald
Journal:  Circulation       Date:  1965-11       Impact factor: 29.690

6.  Intra aortic balloon pumping in myocardial infarction and unstable angina.

Authors:  R Michels; M Haalebos; P P Kint; F Hagemeijer; K Balakumaran; M van der Brand; P W Serruys; P G Hugenholtz
Journal:  Eur Heart J       Date:  1980-02       Impact factor: 29.983

7.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

8.  Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.

Authors:  C Richard; J L Ricome; A Rimailho; G Bottineau; P Auzepy
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

9.  Inotropic and vasodilator effects of amrinone on isolated human tissue.

Authors:  P T Wilmshurst; J M Walker; C H Fry; J P Mounsey; C H Twort; B T Williams; M J Davies; M M Webb-Peploe
Journal:  Cardiovasc Res       Date:  1984-05       Impact factor: 10.787

10.  Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.

Authors:  M Renard; P Jacobs; I Liebens; A Friart; R Bernard
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.